Amylyx to present Phase 3 avexitide trial data at ObesityWeek 2026

October 6, 2026 8:01 AM

Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) will present topline results from its Phase 3 LUCIDITY clinical trial of avexitide at the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found